This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Van Poznak, C. Search for Related Content PubMed Articles by Van Poznak, C.

Osteonecrosis of the Jaw

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Catherine Van Poznak, MD

With broadened and prolonged use of bisphosphonates for advanced cancer becoming more common, osteonecrosis of the jaw (ONJ) has become a concern. We know little about the pathogenesis of ONJ, we cannot reliably predict who is at greatest risk for its development, and we cannot control the condition easily once it is diagnosed. These unknowns make ONJ worrisome to patients, clinicians, and those in the pharmaceutical field. The article by Ruggiero et al,¹ published in this issue of the Journal of Oncology Practice, sheds some light on ONJ by outlining what is and is not . . . [Click for More]